(otc pink:gogc)
Post on 13-Mar-2016
75 Views
Preview:
DESCRIPTION
TRANSCRIPT
(OTC Pink:GOGC)(OTC Pink:GOGC)
Forward-Looking Forward-Looking StatementStatement
This presentation contains statements that constitute This presentation contains statements that constitute ““forward-lookingforward-looking”” statements within statements withinthe meaning of the Securities Act of 1993 and the Securities Exchange Act of 1934, as the meaning of the Securities Act of 1993 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. amended by the Private Securities Litigation Reform Act of 1995. ““Forward-lookingForward-looking”” statements contained in this presentation include the intent, belief or current expectationsstatements contained in this presentation include the intent, belief or current expectationsof the Company and its senior management team with respect to future actions by the of the Company and its senior management team with respect to future actions by the Company, prospects of the CompanyCompany, prospects of the Company’’s operations, profits from future operations, overall s operations, profits from future operations, overall future business prospects and long-term stockholder value, as well as the assumptions future business prospects and long-term stockholder value, as well as the assumptions upon which such statements are based.upon which such statements are based.
Investors are cautioned that any such Investors are cautioned that any such ““forward-lookingforward-looking”” statements are not guarantees of statements are not guarantees offuture performance, and that actual results may differ materially from those contemplated future performance, and that actual results may differ materially from those contemplated by such by such ““forward-lookingforward-looking”” statements. Important factors currently known to management statements. Important factors currently known to managementthat could cause actual results to differ materially from those contemplated by the that could cause actual results to differ materially from those contemplated by the ““forward-lookingforward-looking”” statement in this presentation include, but are not limited to, adverse statement in this presentation include, but are not limited to, adversedevelopments involving operations of the Companydevelopments involving operations of the Company’’s business units, failure to meet s business units, failure to meet operating objectives or to execute the business plan, the failure to reach revenue or profit operating objectives or to execute the business plan, the failure to reach revenue or profit projections and the failure to retain and hire key personnel and management. The projections and the failure to retain and hire key personnel and management. The Company undertakes no obligation to update or revise the Company undertakes no obligation to update or revise the ““forward-lookingforward-looking”” statements statements contained in this presentation to reflect changed assumptions, the occurrence of contained in this presentation to reflect changed assumptions, the occurrence of unanticipated events, or changes to future operating results over time.unanticipated events, or changes to future operating results over time.
Corporate Corporate DescriptionDescription
Global Green, Inc. introduces Global Green, Inc. introduces Salmogenics™,Salmogenics™,
a new patented vaccine to help combat a new patented vaccine to help combat the dangerous effects that Salmonella the dangerous effects that Salmonella
bacteria produce in animals and human bacteria produce in animals and human beings. Global Green, upon USDA beings. Global Green, upon USDA
approval, plans to manufacture, market approval, plans to manufacture, market and sell and sell
the vaccine in the poultry industry. the vaccine in the poultry industry.
A unique, new patented vaccine to A unique, new patented vaccine to combat the devastating effects of combat the devastating effects of
SalmonellaSalmonella
Why This Vaccine?Why This Vaccine?
No Live Injection
In-Ovo Injection
Healthier Chicken
Company HighlightsCompany Highlights
Worldwide Market OpportunityWorldwide Market Opportunity Exclusive Rights to Two Patents Owned by Exclusive Rights to Two Patents Owned by
N.H.I.L., a research affiliate and majority N.H.I.L., a research affiliate and majority shareholdershareholder
Only Source of New Patented Vaccine Offering: Only Source of New Patented Vaccine Offering: Protection from deadly Salmonella bacteriaProtection from deadly Salmonella bacteria Healthier protein source Healthier protein source Potential to improve the lives of millions of peoplePotential to improve the lives of millions of people
Product Expansion PotentialProduct Expansion Potential
AgendaAgenda
Market OpportunityMarket Opportunity
Business StrategyBusiness Strategy
Market Market OpportunityOpportunity
Market OverviewMarket Overview Approximately 1.3 billion humans Approximately 1.3 billion humans
contract salmonella annually, with 2-3 contract salmonella annually, with 2-3 million resulting in deathmillion resulting in death
1 million humans in the U.S. contract 1 million humans in the U.S. contract salmonella annuallysalmonella annually
40 billion chickens will benefit from 40 billion chickens will benefit from the salmonella vaccinethe salmonella vaccine
Salmonella is the scientific name for Salmonella is the scientific name for over 2,500 types of bacteriaover 2,500 types of bacteria
The Problem is PublicThe Problem is Public““Salmonella is common in poultry, so Salmonella is common in poultry, so
itit’’s not illegal fors not illegal for meat to be tainted with the pathogen.meat to be tainted with the pathogen.””
CBS News, August 2011CBS News, August 2011
““For every laboratory-confirmed case of For every laboratory-confirmed case of Salmonella, there are at least 29 Salmonella, there are at least 29
unreported cases.unreported cases.”” Centers for Disease Centers for Disease Control, 2011Control, 2011
2010 USDA Mandate2010 USDA MandateReduce the percentage of Reduce the percentage of
Salmonella infected chicken Salmonella infected chicken allowed on the market from 7% allowed on the market from 7%
to 5%to 5%
Salmogenics has been shown in Salmogenics has been shown in efficacy studies to help accomplish efficacy studies to help accomplish
these strict requirementsthese strict requirements
USDA Approval ProgressUSDA Approval Progress
In last stages of testing and trialsIn last stages of testing and trials Vaccine proven to be safe, non-toxic Vaccine proven to be safe, non-toxic
and causes no harm to the animal and causes no harm to the animal Studies to date conclude that Studies to date conclude that
Salmogenics reduces Salmonella Salmogenics reduces Salmonella contaminationcontamination
USDA Final Phase StatusUSDA Final Phase Status Identify and contract USDA-approved Identify and contract USDA-approved
vaccine manufacturervaccine manufacturer Assure requirements from the vaccine Assure requirements from the vaccine
manufacturer will meet USDA requirementsmanufacturer will meet USDA requirements Conclusion submitted to USDA must specify:Conclusion submitted to USDA must specify:
vaccine product can be safely and standardly vaccine product can be safely and standardly commercially applied by the intended customerscommercially applied by the intended customers
claims are sustainable and reproducible when claims are sustainable and reproducible when applied to larger populations of birdsapplied to larger populations of birds
vaccine can be used in other circumstances such vaccine can be used in other circumstances such as a combined treatment with other vaccinesas a combined treatment with other vaccines
Submit final results to USDA for approvalSubmit final results to USDA for approval
A A provenproven solution to reducing the solution to reducing the incidence and prevalence of incidence and prevalence of Salmonella in poultry, which can Salmonella in poultry, which can cause food poisoning in humanscause food poisoning in humans
Changes the Changes the approach approach to the to the control of the spread of an control of the spread of an economically devastating diseaseeconomically devastating disease
Organic Poultry Retail Organic Poultry Retail Market SalesMarket Sales
0
100
200
300
400
500
600
2005 2010
$161 Million
Source: USDA
$600Million
Source: Dolcera Analysis
Key Growth DriversKey Growth DriversPoultry Vaccine MarketPoultry Vaccine Market
(Estimated to be $5.4 billion by 2015)(Estimated to be $5.4 billion by 2015)
Growth of diseases in animalsGrowth of diseases in animals Increasing public awarenessIncreasing public awareness Technological advancementsTechnological advancements Ability of vaccines toAbility of vaccines to
Promote growthPromote growth Develop immunity against diseasesDevelop immunity against diseases Lower animal mortality rateLower animal mortality rate
Source: Global Industry Analysts
Potential Problems with Water Potential Problems with Water Borne or Spray Vaccinations Borne or Spray Vaccinations
with Chickenswith Chickens Multiple poultry caretakers involvedMultiple poultry caretakers involved Variety of vaccination equipment usedVariety of vaccination equipment used Re-use of containers = vaccine residuesRe-use of containers = vaccine residues Defective vaccine distribution patternsDefective vaccine distribution patterns Mixing vaccines for a complete dayMixing vaccines for a complete day Incorrect dosage of vaccine or diluentIncorrect dosage of vaccine or diluent
End ResultEnd Result::Added human interactions + labor costs + Added human interactions + labor costs +
stressstresson poultryon poultry
Advantages of In Ovo Vaccinations
Earlier immunityEarlier immunity Uniform deliveryUniform delivery Fast deliveryFast delivery Reduced stressReduced stress Reduced labor Reduced labor
costscosts Future productsFuture products
Egg Yolk Needle
Air ChamberShell
The Global Green The Global Green AdvantageAdvantage
is is SignificantSignificant•Earlier immunity•Uniform delivery•Fast delivery•Reduced stress•Reduced labor costs•Improved productivity•Future products
Benefits to the Entire Benefits to the Entire SystemSystem
Poultry GrowersPoultry Growers Fast deliveryFast delivery Uniform delivery systemUniform delivery system Reduced labor costs for Reduced labor costs for
inoculationinoculation
ChickenChicken Less traumaLess trauma Earlier immunity from Earlier immunity from
SalmonellaSalmonella
HumansHumans Healthier protein sourceHealthier protein source
EnvironmentEnvironment Environmentally Environmentally
friendlyfriendly
Food Service Handlers Reduced Reduced contaminationcontamination Healthier customers Healthier customers and and familiesfamilies
OtherVaccines
LiveBird
Incompatible with Marek’s Disease VaccineIncreased
Cost
Non-Standardized Dosage Delivery
More Susceptible to Secondary Infections
Labor Intensive
Trauma
Less Cost, Higher Conversion, Healthier Humans
Salmogenics In Ovo
Improved Conversion
Reduced
Cost
No Trauma
Early Immunity
Uniform Delivery
Compatible with Marek’s Disease Vaccine
Additional Market Applications
Salmogenics = Safer Egg
Worldwide egg market =
1.3 trillion eggs per year
+
Business Business StrategyStrategy
Business StrategyBusiness Strategy Complete final requirements for USDA approvalComplete final requirements for USDA approval Receive final approval by USDAReceive final approval by USDA Develop marketing and sales structure to Develop marketing and sales structure to
effectively convert market to Salmogenicseffectively convert market to Salmogenics Establish Salmogenics as standard in the Establish Salmogenics as standard in the
industryindustry Innovate through internal new product Innovate through internal new product
developmentdevelopment Establish a leadership position in vaccine Establish a leadership position in vaccine
technology with Salmogenics as the foundationtechnology with Salmogenics as the foundation
Top 10 Broiler Chicken Top 10 Broiler Chicken CompaniesCompanies
Representing 73.7% of Chickens Processed AnnuallyRepresenting 73.7% of Chickens Processed Annually#1#1 Tyson Foods, Inc.Tyson Foods, Inc.#2#2 PilgrimPilgrim’’s Pride Corp.s Pride Corp.#3#3 Perdue Farms, Inc.Perdue Farms, Inc.#4#4 Sanderson Farms, Inc.Sanderson Farms, Inc.#5#5 Koch Foods, Inc.Koch Foods, Inc.#6#6 Wayne Farms, LLCWayne Farms, LLC#7#7 Mountainaire Farms, Inc.Mountainaire Farms, Inc.#8#8 House of Raeford Farms, Inc.House of Raeford Farms, Inc.#9#9 Foster Farms, Inc.Foster Farms, Inc.#10#10 Peco Foods, Inc.Peco Foods, Inc.Source:Source: Watt PoultryUSA Feb 2010Watt PoultryUSA Feb 2010
PastDeveloped Salmogenics vaccine
PresentIntense focus on sales and marketing strategy is gaining traction
FutureGrowth and profitability
Global Green Evolution and Growth Trajectory
Market Penetration Market Penetration StrategiesStrategies
Strong and reliable regulatory approvalsStrong and reliable regulatory approvals Research data publicationsResearch data publications Company and product name recognitionCompany and product name recognition Advertising in leading publicationsAdvertising in leading publications
Animal productionAnimal production Food safetyFood safety
Strong and experienced technical staff Strong and experienced technical staff working with poultry industry expertsworking with poultry industry experts
Strong sales force focusing on top tier Strong sales force focusing on top tier customerscustomers
Major Players in Veterinary Major Players in Veterinary Vaccine MarketVaccine Market
Source: Company Annual Reports
Company Revenues from Animal
Health in 2010 ($ Bn)
Pfizer 3.575 Merck 2.900 Sanofi-Aventis 2.635 Bayer Healthcare 0.800 Virbac 0.781 Novartis 0.500 Boehringer Ingelheim 0.354 Heska Corporation 0.065
Salmogenics Salmogenics Competitive AdvantagesCompetitive Advantages
Patent positionsPatent positions Improved immune system of fowl = Improved immune system of fowl =
improved health and welfare of bird improved health and welfare of bird and humansand humans
Healthier chickens = healthier protein Healthier chickens = healthier protein sourcesource
Vaccine injected directly into egg = Vaccine injected directly into egg = reduced time and labor costsreduced time and labor costs
End result = success of SalmogenicsEnd result = success of Salmogenics
TimelineTimeline 1986 – Dr. Sotomayor began research on animal 1986 – Dr. Sotomayor began research on animal
health vaccineshealth vaccines 1995 – Technology brought to U.S.1995 – Technology brought to U.S. 1997 – USDA approved validation study begins1997 – USDA approved validation study begins 2008 – NHIL secures worldwide rights to 2008 – NHIL secures worldwide rights to
SalmogenicsSalmogenics 2010 – Studies as required by USDA contracted to 2010 – Studies as required by USDA contracted to
AHPharmaAHPharma 2010 – NHIL grants Salmogenics rights to Global 2010 – NHIL grants Salmogenics rights to Global
GreenGreen Feb 2011 – USDA Phase 4 trials beganFeb 2011 – USDA Phase 4 trials began May 2011 – Receive patent on vaccine compositionMay 2011 – Receive patent on vaccine composition
Timeline Timeline (cont(cont’’d)d) Aug 2011 – Receive patent on method and Aug 2011 – Receive patent on method and
composition composition Oct 2011 – SEC approves Form S-1 (IPO) Oct 2011 – SEC approves Form S-1 (IPO) Nov 2011 – Phase 4 Salmonella challenge Nov 2011 – Phase 4 Salmonella challenge
study completedstudy completed March 2012 – FINRA approvalMarch 2012 – FINRA approval March 2012 – Final report on Phase 4 March 2012 – Final report on Phase 4
Efficacy/Challenge studyEfficacy/Challenge study April 2012 – DTC application filedApril 2012 – DTC application filed April/May - USDA-approved production April/May - USDA-approved production
facility to be chosenfacility to be chosen
The Management TeamThe Management TeamNameName FunctionFunctionDr. Mehran Ghazvini, DC,NMDDr. Mehran Ghazvini, DC,NMD Chairman, Chairman,
CEOCEOand Treasurerand Treasurer
Dr. Rene Reed, DC, NMD Dr. Rene Reed, DC, NMD VP, SecretaryVP, Secretaryand Directorand Director
Investment HighlightsInvestment Highlights Worldwide Market OpportunityWorldwide Market Opportunity Proprietary Patent PositionsProprietary Patent Positions Focused on Contributing to Human Focused on Contributing to Human
Welfare through Technology in Welfare through Technology in Vaccines and other NutraceuticalsVaccines and other Nutraceuticals
Well Positioned for the FutureWell Positioned for the Future American-MadeAmerican-Made
top related